Phenylalanine and phenylacetate adversely affect developing mammalian brain neurons

Area of Science:

• Neuroscience
• Biochemistry
• Developmental Biology

Background:

• Phenylketonuria (PKU) is primarily associated with myelin defects.
• Clinical and histological brain changes in PKU suggest potential neuronal damage.
• The exact mechanisms of neuronal insult in PKU require further investigation.

Purpose of the Study:

• To investigate the direct effects of phenylalanine and phenylacetate on immature mammalian cortical neurons.
• To assess the impact of chronic exposure to these metabolites on neuronal function and viability.

Main Methods:

• Primary cortical neuronal cultures from immature mammals were used.
• Cultures were chronically exposed to phenylalanine (0.6 mM) and phenylacetate (0.6 mM).
• Assays included 125I-tetanus toxin binding, choline acetyltransferase activity, 3H-GABA uptake, and glutamic acid decarboxylase activity.

Main Results:

• Exposure to either phenylalanine or phenylacetate led to neuronal dropout.
• Both metabolites significantly decreased 125I-tetanus toxin binding, a marker of neuronal integrity.
• Choline acetyltransferase activity, high-affinity 3H-GABA uptake, and glutamic acid decarboxylase activity were reduced.

Conclusions:

• Chronic exposure to phenylalanine or phenylacetate has detrimental effects on cultured cortical neurons.
• Both cholinergic and GABAergic neuronal functions are adversely affected.
• Neither phenylalanine nor phenylacetate demonstrated greater potency in causing these adverse effects.